These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 21632857

  • 1. Phase I study utilizing a novel antigen-presenting cell-targeted vaccine with Toll-like receptor stimulation to induce immunity to self-antigens in cancer patients.
    Morse MA, Chapman R, Powderly J, Blackwell K, Keler T, Green J, Riggs R, He LZ, Ramakrishna V, Vitale L, Zhao B, Butler SA, Hobeika A, Osada T, Davis T, Clay T, Lyerly HK.
    Clin Cancer Res; 2011 Jul 15; 17(14):4844-53. PubMed ID: 21632857
    [Abstract] [Full Text] [Related]

  • 2. Toll-like receptor agonists shape the immune responses to a mannose receptor-targeted cancer vaccine.
    He LZ, Weidlick J, Sisson C, Marsh HC, Keler T.
    Cell Mol Immunol; 2015 Nov 15; 12(6):719-28. PubMed ID: 25345808
    [Abstract] [Full Text] [Related]

  • 3. CDX-1307: a novel vaccine under study as treatment for muscle-invasive bladder cancer.
    Morse MA, Bradley DA, Keler T, Laliberte RJ, Green JA, Davis TA, Inman BA.
    Expert Rev Vaccines; 2011 Jun 15; 10(6):733-42. PubMed ID: 21692696
    [Abstract] [Full Text] [Related]

  • 4. Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205.
    Dhodapkar MV, Sznol M, Zhao B, Wang D, Carvajal RD, Keohan ML, Chuang E, Sanborn RE, Lutzky J, Powderly J, Kluger H, Tejwani S, Green J, Ramakrishna V, Crocker A, Vitale L, Yellin M, Davis T, Keler T.
    Sci Transl Med; 2014 Apr 16; 6(232):232ra51. PubMed ID: 24739759
    [Abstract] [Full Text] [Related]

  • 5. Toll-like receptor activation enhances cell-mediated immunity induced by an antibody vaccine targeting human dendritic cells.
    Ramakrishna V, Vasilakos JP, Tario JD, Berger MA, Wallace PK, Keler T.
    J Transl Med; 2007 Jan 25; 5():5. PubMed ID: 17254349
    [Abstract] [Full Text] [Related]

  • 6. Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responses.
    Feder-Mengus C, Schultz-Thater E, Oertli D, Marti WR, Heberer M, Spagnoli GC, Zajac P.
    Hum Gene Ther; 2005 Mar 25; 16(3):348-60. PubMed ID: 15812230
    [Abstract] [Full Text] [Related]

  • 7. Granulocyte/macrophage-colony stimulating factor produced by recombinant avian poxviruses enriches the regional lymph nodes with antigen-presenting cells and acts as an immunoadjuvant.
    Kass E, Panicali DL, Mazzara G, Schlom J, Greiner JW.
    Cancer Res; 2001 Jan 01; 61(1):206-14. PubMed ID: 11196163
    [Abstract] [Full Text] [Related]

  • 8. Granulocyte-macrophage colony-stimulating factor: an effective adjuvant for protein and peptide-based vaccines.
    Disis ML, Bernhard H, Shiota FM, Hand SL, Gralow JR, Huseby ES, Gillis S, Cheever MA.
    Blood; 1996 Jul 01; 88(1):202-10. PubMed ID: 8704175
    [Abstract] [Full Text] [Related]

  • 9. Soluble cytokines can act as effective adjuvants in plasmid DNA vaccines targeting self tumor antigens.
    Disis ML, Shiota FM, McNeel DG, Knutson KL.
    Immunobiology; 2003 Jul 01; 207(3):179-86. PubMed ID: 12777059
    [Abstract] [Full Text] [Related]

  • 10. Immunization with a tumor-cell-lysate-loaded autologous-antigen-presenting-cell-based vaccine in melanoma.
    Chakraborty NG, Sporn JR, Tortora AF, Kurtzman SH, Yamase H, Ergin MT, Mukherji B.
    Cancer Immunol Immunother; 1998 Sep 01; 47(1):58-64. PubMed ID: 9755879
    [Abstract] [Full Text] [Related]

  • 11. Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies.
    Nelson WG, Simons JW, Mikhak B, Chang JF, DeMarzo AM, Carducci MA, Kim M, Weber CE, Baccala AA, Goeman MA, Clift SM, Ando DG, Levitsky HI, Cohen LK, Sanda MG, Mulligan RC, Partin AW, Carter HB, Piantadosi S, Marshall FF.
    Cancer Chemother Pharmacol; 2000 Sep 01; 46 Suppl():S67-72. PubMed ID: 10950151
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Small cationic DDA:TDB liposomes as protein vaccine adjuvants obviate the need for TLR agonists in inducing cellular and humoral responses.
    Milicic A, Kaur R, Reyes-Sandoval A, Tang CK, Honeycutt J, Perrie Y, Hill AV.
    PLoS One; 2012 Sep 01; 7(3):e34255. PubMed ID: 22470545
    [Abstract] [Full Text] [Related]

  • 14. Targeted Codelivery of an Antigen and Dual Agonists by Hybrid Nanoparticles for Enhanced Cancer Immunotherapy.
    Zhang L, Wu S, Qin Y, Fan F, Zhang Z, Huang C, Ji W, Lu L, Wang C, Sun H, Leng X, Kong D, Zhu D.
    Nano Lett; 2019 Jul 10; 19(7):4237-4249. PubMed ID: 30868883
    [Abstract] [Full Text] [Related]

  • 15. Priming tissue-specific cellular immunity in a phase I trial of autologous dendritic cells for prostate cancer.
    Burch PA, Breen JK, Buckner JC, Gastineau DA, Kaur JA, Laus RL, Padley DJ, Peshwa MV, Pitot HC, Richardson RL, Smits BJ, Sopapan P, Strang G, Valone FH, Vuk-Pavlović S.
    Clin Cancer Res; 2000 Jun 10; 6(6):2175-82. PubMed ID: 10873066
    [Abstract] [Full Text] [Related]

  • 16. TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours.
    Conroy H, Marshall NA, Mills KH.
    Oncogene; 2008 Jan 07; 27(2):168-80. PubMed ID: 18176598
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity.
    Huleatt JW, Jacobs AR, Tang J, Desai P, Kopp EB, Huang Y, Song L, Nakaar V, Powell TJ.
    Vaccine; 2007 Jan 08; 25(4):763-75. PubMed ID: 16968658
    [Abstract] [Full Text] [Related]

  • 20. Anti-Gal-mediated targeting of human B lymphoma cells to antigen-presenting cells: a potential method for immunotherapy using autologous tumor cells.
    Manches O, Plumas J, Lui G, Chaperot L, Molens JP, Sotto JJ, Bensa JC, Galili U.
    Haematologica; 2005 May 08; 90(5):625-34. PubMed ID: 15921377
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.